Clinical trial tests promising CAR T-cell therapy for lupus - Takeaways - MDSpire

Clinical trial tests promising CAR T-cell therapy for lupus

UCI Health has launched a groundbreaking clinical trial for a next-generation CAR T-cell therapy.

Share

1

UCI Health is conducting a clinical trial for FT819, a CAR T-cell therapy for systemic lupus erythematosus.
2

The trial is led by Dr. Sheetal Desai, Chief of the Division of Rheumatology at UCI.
3

FT819 aims to provide long-term remission for patients with moderate to severe lupus unresponsive to standard treatments.
4

This therapy differs from traditional CAR T-cell methods by not requiring patient cell harvesting and reprogramming.
5

Early results show promise, with a participant experiencing significant symptom reversal and regained function.